AzTrials
AzTrials

Health-Related BehaviorPODERNCT05713617

PODER Familiar: Health Promotion for Latino Families of Children With IDD

A study testing PODER Familiar in people with Health-Related Behavior and Quality of Life, run by University of Texas at Austin at 2 sites in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to test a culturally tailored health promotion intervention for children with IDD and their families. First investigators will conduct a single group design pilot study of a health promotion intervention, followed by second, a small-scale randomized control trial (RCT). Read more about this study

Who is it for?
Ages 6 to 100 yearsHealthy volunteers can take part
What is being tested?
PODER Familiar
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
2 sitesUnited States
Study dates
17 Jan 2023to 30 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Parent/Caregiver
  • identify as parent or primary family caregiver
  • 18 years of age or older
  • Identify as Latino/a or of Latin American Descent
  • have a child with IDD between 6 and 17 years of age Child with IDD
  • between 6 and 17 years old
  • the child has a diagnosis of autism spectrum disorder, Down syndrome or intellectual disability

Who cannot join

  • Child uses mobility aid

Trial locations and contacts

2 sites in 1 country.

United States2 sites, 2 recruiting
  • Steve Hicks School of Social Work, University of Texas at Austin

    Austin, Texas, 78712

    Desiree Pacheco, 512-471-1937, desiree.pacheco@austin.utexas.edu

    Sandy Magana, 512-232-9216, smagana@austin.utexas.edu

    Recruiting
  • University of Illinois at Chicago

    Chicago, Illinois, 60612

    Yolanda Suarez-Balcazar, PhD, 312-413-0117, ysuarez@uic.edu

    Mansha Mirza, PhD, 312-355-5427, mmirza2@uic.edu

    Recruiting

Other trials in United States

About this study

Official title: PODER Familiar: A Health Promotion Intervention for Latino Families of Children With Intellectual and Developmental Disabilities

The goal of this clinical trial is to test a culturally tailored health promotion intervention for children with IDD and their families. First investigators will conduct a single group design pilot study of a health promotion intervention, followed by second, a small-scale randomized control trial (RCT). of the intervention with Latino parents of children with intellectual and developmental disabilities (IDD) in the Chicago, Illinois and Austin, Texas areas. The following research questions will be addressed:

Question 1: What is the appropriate content, dosage, and delivery method of the intervention?

Read more

Question 2: What is the feasibility and acceptability of the intervention?

Question 3: Do participants improve between pre and post-test on outcome measures both in the one group design and compared to the control group in the RCT?

Parents will receive 10 weekly remote sessions on health promotion content delivered by parent mentors called promotoras. Parents and children will attend 3 multi-family group workshops in-person that will provide demonstrations and interactive activities.

Read the detailed description

PODER Familiar will consist of 10 weekly remote one-on-one sessions with the parent and the promotora, and 3 monthly multi-group family sessions to be held in-person. The weekly remote sessions will be conducted on a video-chat platform The multi-group family sessions will be held at a community friendly location (a community center or space at a community organization) in which 3 to 5 families will attend. Family units will consist of the parent and child with IDD and other family members who wish to attend (other parent, siblings, etc.). Group sessions will reinforce content covered in the curriculum through interactive activities and demonstrations.

The promotoras who deliver the weekly sessions will be bilingual and will also be parents of children with IDD. They will offer the sessions in the language of preference of the participant. Promotoras will receive 15 hours of training on content and procedures. Individual sessions will be audio-recorded and reviewed for fidelity, training and consistency.

The group sessions will be conducted by the PIs and graduate students at each site. Groups will be conducted in Spanish and English.

Phase I: Piloting the Intervention (Research Questions 1 \&2) Phase I will consist of a one group pre and post-test design with no control group.

Sample and Recruitment. Thirty Latino families will be recruited for the pilot study (15 in Chicago, and 15 in Austin). Community organizations will help recruit eligible families using an informational flyer about the study and an accompanying verbal recruitment script. All recruitment materials will be translated to Spanish. Families who express interest in participation will be contacted by a trained bilingual research assistant to complete consent forms and to schedule the baseline assessment. After a cohort of 15 families has been recruited at each site, the pilot intervention will be scheduled.

Data Source/Data Collection. Parents/caregivers will complete objective and self-report assessments at baseline and post-intervention follow-up through telephone or video chat interviews with trained students. Two interviews will be conducted at baseline and two at follow-up to collect the full battery of measures.

At baseline and again at follow-up, participants will be instructed to wear accelerometers (ActiGraph GT3XP-BTLE 2GB) for at least 12 hours over seven consecutive days. The accelerometers will be mailed to the participant after the first baseline and follow-up interview with a return mail postage paid envelope.

Participants will wear the monitor for at least one week and a 15-second time interval will be used. The total minutes per day in moderate to vigorous physical activity and sedentary activity will be computed with Actilife Software Version 6.13 (Actigraph Corp, Pensacola, FL). investigators will use previously established cut points for physical activity, which provide acceptable classification accuracy for all levels of physical activity intensity among children of all ages.

Acceptability measures include: (1) Satisfaction with the intervention, which will be evaluated using a survey to be completed by parents/caregivers after each of the six family group workshop sessions and after the full 12-week intervention. Satisfaction survey will include questions about accessibility and adequacy of participation of youth with IDD. 2) Engagement in the intervention, which will be assessed by study staff rating participants (caregivers and children) on behaviors such as being present for the whole session, verbal interaction in group sessions, and frequency of contact with promotoras. Special attention will be given to the engagement of youth with IDD in all aspects of the group sessions. Feasibility measures include (1) number of families approached for recruitment and number enrolled, (2) reasons for declining, (3) attendance at family group sessions based on attendance logs; participants who miss sessions will be called to inquire about barriers to attendance, (4) retention at post-intervention, (5) completion of the 4-month follow-up, and (6) intervention fidelity. To monitor fidelity, investigators will audio record group and one-on-one sessions. A bilingual research assistant will review recordings against a fidelity checklist to ensure adherence to active ingredients of the intervention. If the session score is <80% on the fidelity checklist, group facilitators and promotoras will be notified to review the intervention content.

Phase II: Exploratory RCT (Research Question 3) The intervention will be modified using feedback from the single arm study, and will be tested using a randomly allocated two-group time series design. This will be an exploratory study to assess preliminary efficacy of the intervention. Investigators will submit an amendment with details on this phase of the study before implementing this phase.

Data Analysis

Phase I: Piloting the Intervention Descriptive statistics will be used to summarize feasibility and acceptability measures. To generate estimates for future trials, investigators will compute group-specific means and standard deviations for outcome measures. Investigators will used student t tests to examine differences between baseline and follow-up on outcome measures.

Qualitative data from focus groups will be tape-recorded. Recordings will be transcribed verbatim in Spanish and translated to English. Transcripts will be imported into Atlas.ti Qualitative Data Analysis Software. English and Spanish transcripts will be reviewed in their original languages using a mixed approach, which combines inductive reasoning with predetermined coding strategies. Using this approach, transcripts will be first reviewed in entirety to understand the scope of the data. Next, investigators will review the transcripts line-by-line and organize data using an a priori coding scheme, which will include (1) conceptual codes (e.g. acceptability of intervention); (2) participant perspective codes (e.g. satisfaction with intervention); (3) participant characteristic codes; (4) intervention-specific codes; and (4) relationship codes (which identify links between other codes). The two reviewers will share emerging codes and a coding dictionary will be developed to guide more specific application of codes. The coding scheme will be sequentially refined until investigators achieve theoretical saturation. Analyzing data in English and Spanish will allow both etic (outsider) and emic (insider) perspectives to emerge. Focus group data will be synthesized, and a summary of the synthesis will be shared with participating families. The researchers will then conduct a member-checking interview with at least three caregiver participants to ensure credibility of the analysis. Inter-coder reliability will be calculated between coders. A high inter-coder reliability may indicate strong coding methods and operational definitions of terms.

Being tested
PODER Familiar
Keywords
healthy lifestyle, Latino families, developmental disabilities
Medical subject headings
Health Behavior, Sedentary Behavior, Developmental Disabilities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PODER FamiliarBehavioural

    Educational intervention designed to improve healthy behaviors of families of children with intellectual and developmental disabilities.

Study groups in NCT05713617
Study groupRoleWhat they receive
Intervention groupExperimentalParticipants will receive 10 remote sessions with the curriculum with a promotora, and 3 in-person group workshops.
Receives: Behavioral: PODER Familiar
control groupNo interventionParticipants will receive community services as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline parent Body Mass Index at 4 months

    Weight and height measurement

    Measured: from baseline to 4 months

  2. Change from baseline parent health-related quality of life at 4 months

    PROMIS Global Health (parent); minimum 9 maximum 45, higher better

    Measured: from baseline to 4 months

  3. Change from baseline parent psychological distress at 4 months

    Center for Epidemiological Studies - Depression, minimum 0 maximum 60, higher worse

    Measured: from baseline to 4 months

  4. Change from baseline child body mass index percentile at 4 months

    weight and height measurement

    Measured: from baseline to 4 months

  5. Change from baseline child health related quality of life at 4 months

    PROMIS Pediatric Scale Global, minimum 7, maximum 35, higher better

    Measured: from baseline to 4 months

Secondary outcomes (4)
  1. Change from baseline parent physical activity at 4 months

    ActiGraph accelerometer, measures 4 categories: sedentary, light, moderate, vigorous PA

    Measured: from baseline to 4 months

  2. Change from baseline parent dietary Intake at 4 months

    Dietary Screener Questionnaire (DSQ) intake of fruit, vegetables, dairy, sugars, \& whole grains

    Measured: from baseline to 4 months

  3. Change from baseline child physical activity at 4 months

    ActiGraph accelerometer, measures 4 categories: sedentary, light, moderate, vigorous PA

    Measured: from baseline to 4 months

  4. Change from baseline child dietary Intake at 4 months

    Dietary Screener Questionnaire (DSQ) intake of fruit, vegetables, dairy, sugars, \& grains

    Measured: from baseline to 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2023
  2. Study start17 Jan 2023
  3. Primary completion30 Sep 2024 (estimated)
  4. Study completion30 Sep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Phase I will be a single arm pre-post-test intervention study; Phase II will be a randomized controlled trial with a treatment and control arm.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05713617
Sponsor's protocol ID
STUDY00003271
Acronym
PODER
Status last verified
Jul 2024
First submitted
16 Dec 2022
Last updated
26 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Our funder requires that we share de-identified data with the Inter-University Consortium for Political and Social Research (ICPSR) no later than 24 months from the completion of the study end date. We will deidentify all data and submit the database to ICPSR according to their specifications.

Publications

  • Yu AP, Suarez-Balcazar Y, Errisuriz VL, Parra-Medina D, Mirza M, Zhang M, Lee PC, Zeng W, Brown-Hollie JP, Yespica Mendoza E, Brown S, Vanegas SB, Heydarian NM, Magana S. PODER Familiar: A Culturally Tailored Health Intervention for Latino Families of Children With Intellectual and Developmental Disabilities. J Appl Res Intellect Disabil. 2025 Mar;38(2):e70048. doi: 10.1111/jar.70048.

    PubMed 40186534

Questions about this trial

What is this clinical trial studying?

A study testing PODER Familiar in people with Health-Related Behavior and Quality of Life, run by University of Texas at Austin at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline parent Body Mass Index at 4 months (time frame: from baseline to 4 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05713617, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in